Arrowhead Pharmaceuticals, Inc. (ARWR)
77.91
-1.14
(-1.44%)
USD |
NASDAQ |
May 29, 16:00
77.89
-0.02
(-0.03%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Total Liabilities (Quarterly) : 1.669B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.674B |
| Revolution Medicines, Inc. | 753.82M |
| Kymera Therapeutics, Inc. | 129.38M |
| ImmunityBio, Inc. | 1.516B |
| Vera Therapeutics, Inc. | 122.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.268B |
| Shareholders Equity (Quarterly) | 613.98M |
| Debt to Equity Ratio | 2.237 |
| Current Ratio | 6.232 |
| Net Debt Paydown Yield | -1.14% |